{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T19:13:37Z","timestamp":1781982817159,"version":"3.54.5"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Post-transplant lymphoproliferative disorders (PTLD) are diseases occurring in immunocompromised patients after hematopoietic stem cell transplantation (HCT) or solid organ transplantation (SOT). Although PTLD occurs rarely, it may be associated with poor outcomes. In most cases, PTLD is driven by Epstein-Barr virus (EBV) infection. Few studies have investigated the mutational landscape and gene expression profile of PTLD. In our study, we performed targeted deep sequencing and RNA-sequencing (RNA-Seq) on 16 cases of florid follicular hyperplasia (FFH) type PTLD and 15 cases of other PTLD types that include: ten monomorphic (M-PTLD), three polymorphic (P-PTLD), and two classic Hodgkin lymphoma type PTLDs (CHL-PTLD). Our study identified recurrent mutations in <jats:italic>JAK3<\/jats:italic> in five of 15 PTLD cases and one of 16 FFH-PTLD cases, as well as 16 other genes that were mutated in M-PTLD, P-PTLD, CHL-PTLD and FFH-PTLD. Digital image analysis demonstrated significant differences in single cell area, major axis, and diameter when comparing cases of M-PTLD and P-PTLD to FFH-PTLD. No morphometric relationship was identified with regards to a specific genetic mutation. Our findings suggest that immune regulatory pathways play an essential role in PTLD, with the <jats:italic>JAK<\/jats:italic>\/<jats:italic>STAT<\/jats:italic> pathway affected in many PTLDs.<\/jats:p>","DOI":"10.3389\/fonc.2021.790481","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T06:42:09Z","timestamp":1642401729000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Mutations in JAK\/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders"],"prefix":"10.3389","volume":"11","author":[{"given":"Alexandra","family":"Butzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwash","family":"Jangam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Ohgami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"B1","volume-title":"WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, Revised 4th Ed","author":"Swerdlow","year":"2017"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v6.i3.505","article-title":"Recent Insights in the Pathogenesis of Post-Transplantation Lymphoproliferative Disorders","volume":"6","author":"Morscio","year":"2016","journal-title":"World J Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/hon.859","article-title":"Genetic and Phenotypic Analysis of B-Cell Post-Transplant Lymphoproliferative Disorders Provides Insights Into Disease Biology","volume":"26","author":"Vakiani","year":"2008","journal-title":"Hematol Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/PDM.0b013e31804f54a9","article-title":"Gene Expression Profiling of Epstein-Barr Virus-Positive","volume":"16","author":"Craig","year":"2007","journal-title":"Diagn Mol Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12196","article-title":"Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders","volume":"13","author":"Morscio","year":"2013","journal-title":"Am J Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13558","article-title":"EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features","volume":"16","author":"Ferreiro","year":"2016","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/bjh.14633","article-title":"Mutational Landscape of B-Cell Post-Transplant Lymphoproliferative Disorders","volume":"178","author":"Menter","year":"2017","journal-title":"Br J Haematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-019-04284-w","article-title":"Biomarkers for PTLD Diagnosis and Therapies","volume":"35","author":"Martinez","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4686","article-title":"A Comprehensive Analysis of RHOA Mutation Positive and Negative Angioimmunoblastic T-Cell Lymphomas by Targeted Deep Sequencing, Expression Profiling and Single Cell Digital Image Analysis","volume":"46","author":"Butzmann","year":"2020","journal-title":"Int J Mol Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/mco.2020.2043","article-title":"Significance of Bacterial and Viral Genotypes as a Risk Factor in Driving Cancer","volume":"13","author":"Jangam","year":"2020","journal-title":"Mol Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic Variant Annotation and Prioritization With ANNOVAR and Wannovar","volume":"10","author":"Yang","year":"2015","journal-title":"Nat Protoc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-018-0539-0","article-title":"Mutationalpatterns: Comprehensive Genome-Wide Analysis of Mutational Processes","volume":"10","author":"Blokzijl","year":"2018","journal-title":"Genome Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: Interactive and Collaborative HTML5 Gene List Enrichment Analysis Tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinf"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ng1180","article-title":"Pgc-1\u03b1-Responsive Genes Involved in Oxidative Phosphorylation Are Coordinately Downregulated in Human Diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1055","article-title":"The Consensuspathdb Interaction Database: 2013 Update","volume":"41","author":"Kamburov","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"23532","DOI":"10.1038\/srep23532","article-title":"Metagenomic Analysis of Bloodstream Infections in Patients With Acute Leukemia and Therapy-Induced Neutropenia","volume":"6","author":"Gyarmati","year":"2016","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12859-018-2260-9","article-title":"HGT-ID: An Efficient and Sensitive Workflow to Detect Human-Viral Insertion Sites Using Next-Generation Sequencing Data","volume":"19","author":"Baheti","year":"2018","journal-title":"BMC Bioinf"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv468","article-title":"Clustvis: A Web Tool for Visualizing Clustering of Multivariate Data Using Principal Component Analysis and Heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Web Serv issue Publ Online"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data With Deseq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13059-019-1842-9","article-title":"Accuracy Assessment of Fusion Transcript Detection via Read-Mapping and De Novo Fusion Transcript Assembly-Based Methods","volume":"20","author":"Haas","year":"2019","journal-title":"Genome Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust Enumeration of Cell Subsets From Tissue Expression Profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0188717","DOI":"10.1371\/journal.pone.0188717","article-title":"Unsupervised Morphological Segmentation of Tissue Compartments in Histopathological Images","volume":"12","author":"Fouad","year":"2017","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fonc.2018.00560","article-title":"Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase Domain","volume":"8","author":"Raivola","year":"2018","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200375","article-title":"Revised Exon\u00f0 Intron Structure of Human JAK3 Locus","volume":"7","author":"Brooimans","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200003000-00006","article-title":"Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Disorders: A Distinct Entity","volume":"24","author":"Nelson","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.08.014","article-title":"Cytogenetic Analysis of B-Cell Posttransplant Lymphoproliferations Validates the World Health Organization Classification and Suggests Inclusion of Florid Follicular Hyperplasia as a Precursor Lesion","volume":"38","author":"Vakiani","year":"2007","journal-title":"Hum Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13525","article-title":"Mutations in the Signal Transducer and Activator of Transcription Family of Genes in Cancer","volume":"109","author":"Shahmarvand","year":"2018","journal-title":"Cancer Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-797597","article-title":"Mutant JAK3 Signaling Is Increased by Loss of Wild-Type JAK3 or by Acquisition of Secondary JAK3 Mutations in T-ALL","volume":"131","author":"Degryse","year":"2018","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00019","article-title":"Genomic Profiling of T-Cell Neoplasms Reveals Frequent JAK1 and JAK3 Mutations With Clonal Evasion From Targeted Therapies","volume":"2018","author":"Greenplate","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00023","article-title":"Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India","volume":"10","author":"Aluri","year":"2019","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.391","article-title":"JAK3 Mutations in Italian Patients Affected by SCID: New Molecular Aspects of a Long-Known Gene","volume":"6","author":"Di Matteo","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018019950","article-title":"Driver Mutations in Janus Kinases in a Mouse Model of B-Cell Leukemia Induced by Deletion of PU.1 and Spi-B","volume":"2","author":"Batista","year":"2018","journal-title":"Blood Adv"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20140712","article-title":"The Molecular Regulation of Janus Kinase (JAK) Activation","volume":"462","author":"Babon","year":"2014","journal-title":"Biochem J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2807","article-title":"Structural Basis of Ifn\u03b1 Receptor Recognition by TYK2","volume":"21","author":"Wallweber","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2017.00071","article-title":"The Janus Kinase (JAK) Ferm and SH2 Domains: Bringing Specificity to JAK-Receptor Interactions","volume":"8","author":"Ferrao","year":"2017","journal-title":"Front Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.phrs.2016.07.038","article-title":"Invited Review Janus Kinase (JAK) Inhibitors in the Treatment of Inflammatory and Neoplastic Diseases","volume":"111","author":"Roskoski","year":"2016","journal-title":"Pharmacol Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.10.080","article-title":"Identification of Highly Potent BTK and JAK3 Dual Inhibitors With Improved Activity for the Treatment of B-Cell Lymphoma","volume":"143","author":"Ge","year":"2018","journal-title":"Eur J Med Chem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1594220","article-title":"Combined Use of Tofacitinib (Pan-JAK Inhibitor) and Ruxolitinib (a JAK1\/2 Inhibitor) for Refractory T-Cell Prolymphocytic Leukemia (T-PLL) With a JAK3 Mutation","volume":"60","author":"Gomez-Arteaga","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/path.2789","article-title":"Notch Signalling in T-Cell Lymphoblastic Leukaemia\/Lymphoma and Other Haematological Malignancies","volume":"223","author":"Aster","year":"2011","journal-title":"J Pathol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1880","article-title":"Notch 1 Activation in the Molecular Pathogenesis of T-Cell Acute Lymphoblastic Leukaemia","volume":"6","author":"Grabher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/science.1102160","article-title":"Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e32944","DOI":"10.1371\/journal.pone.0032944","article-title":"Enhanced Notch Activation Is Advantageous But Not Essential for T Cell Lymphomagenesis in Id1 Transgenic Mice","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13859","article-title":"NOTCH1 Pathway Activating Mutations and Clonal Evolution in Pediatric T-Cell Acute Lymphoblastic Leukemia","volume":"110","author":"Kimura","year":"2019","journal-title":"Cancer Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2020190103","article-title":"Posttransplant Proliferative Disorder in Children: A 360-Degree Perspective","volume":"40","author":"Eman","year":"2019","journal-title":"RadoGraphics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001767","article-title":"The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder","volume":"101","author":"Martinez","year":"2017","journal-title":"Transplantation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5500\/wjt.v10.i2.29","article-title":"Post-Transplantation Lymphoproliferative Disorders: Current Concepts and Future Therapeutic Approaches","volume":"10","author":"Abbas","year":"2020","journal-title":"World J Transplant"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08161.x","article-title":"Diagnosis of Post-Transplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients - BCSH and BTS Guidelines","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.790481\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T06:42:13Z","timestamp":1642401733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.790481\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":48,"alternative-id":["10.3389\/fonc.2021.790481"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.790481","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"article-number":"790481"}}